New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology
Written by Black Hot Fire Network on May 26, 2023
– Study findings confirm the importance of improving education among clinicians and streamlining processes to increase adoption of testing in routine cancer care –
SAN FRANCISCO, May 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American . . .
